Fabrication and design of transdermal fluconazole spray Transdermal fluconazole spray

Pharmaceutical Development and Technology

Volumn 14, Issue 2, 2009, Pages 208-215

  Gohel, Mukesh C ^a   Nagori, Stavan A ^a  

^a GUJARAT UNIVERSITY   (India)

Author keywords

Antifungal activity; Fluconazole; In vivo activity; Modified release; Short term stability study; Transdermal spray

Indexed keywords

ALCOHOL; CAMPHOR; ETHYL CELLULOSE; FLUCONAZOLE; FLUCOS; MACROGOL; MENTHOL; UNCLASSIFIED DRUG; ANTIFUNGAL AGENT; CELLULOSE; DRUG DERIVATIVE; MACROGOL DERIVATIVE;

ADULT; AEROSOL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DESIGN; DRUG FORMULATION; DRUG MIXTURE; DRUG STABILITY; DRUG SYNTHESIS; DRUG TRANSPORT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RAT; TINEA; TREATMENT OUTCOME; VISCOSITY; ANIMAL; CANDIDA ALBICANS; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECT; EQUIPMENT DESIGN; INSTRUMENTATION; INTRADERMAL DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SKIN ABSORPTION;

ADMINISTRATION, CUTANEOUS; ADULT; ANIMALS; ANTIFUNGAL AGENTS; CAMPHOR; CANDIDA ALBICANS; CELLULOSE; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EQUIPMENT DESIGN; FLUCONAZOLE; HUMANS; MENTHOL; MIDDLE AGED; POLYETHYLENE GLYCOLS; RATS; SKIN ABSORPTION; TINEA; YOUNG ADULT;

EID: 69249229897     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.1080/10837450802498936     Document Type: Article

References (25)

1. Piérard G, Arrese J, Piérard-Franchimont C. Treatment and prophylaxis of tinea infections. Drugs 1996;52 (2):209-224.
2. Drake LA, Dinehart SM, Farmer ER, Goltz RW,et al . Guidelines of care for superficial mycotic infections of the skin: Tinea corporis, Tinea curis, Tinea faciei, Tinea manuum and Tinea pedis. J. Am. Acad. Dermatol. 1996;34 (2 pt.1):282-286
3. Laura K, Stephanie DT, Christopher JP, Charles LC, David MS. Assessing pregnancy risks of azole antifungals using a high throughput aromatase inhibition assay. Endocrine Res. 2002;28 (3):129-140.
4. El-laithy HM, El-Shaboury KMF. The development of cutina lipogel and gel microemulsion for topical administration of fluconazole. AAPS. PharmSciTech. 2002;3:art. 35.
5. Fekete Pal, Virgula J. Fluconazole capsules with improved release. Patent No., WO2005002553, 2005.
6. Gilis PMV, Conde VFV. Beads having a core coated with an antifungal and a polymer. US Patent No., US5633015, 1997.
7. Lo JB. Method of producing porous delivery devices. Patent No., WO 93/18757, 1993.
8. Brenman B, Leyden JJ. Overview of topical therapy for common superficial fungal infections and the role of new topical agents. J. Am. Acad. Dermatol. 1997;36 (1):53-58.
9. Pattnaik S, Subramanyam VR, Bapaji M, Kole CR. Antibacterial and antifungal activity of aromatic constituents of essential oils. Microbios. 1997;89 (358):39-46.
10. Moleyar V, Narasimham P. Mode of antifungal action of essential oil components citral and camphor. Indian J. Exp. Biol. 1987;25 (11):781-784.
11. Bamba M, Puisievx F, Marty J, Carstensen J. Release mechanism in gel forming sustained release formulation. Int. J. Pharm. 1979;2 (5-6):307-315.
12. Gibaldi M, Feldman S.Establishment of sink conditions in dissolution rate determination. J. Pharm. Sci. 1967;56 (10):1238-1242.
13. Korsmeyer R, Gurny R, Doelker E, Buri P, Peppas N. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983;15 (1):25-35.
14. Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspensions. J. Pharm. Sci. 1961;50 (10):874-875.
15. Higuchi T. Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 1963;52 (12):1145-1149.
16. Higuchi I. Analysis of data on the medicament release from ointments. J. Pharm. Sci. 1962;51 (8):802-804.
17. Langenbucher F. Linearization of dissolution rate curves by the weibull distribution. J. Pharm. Pharmacol. 1972;24 (12):979-989.
18. Schwarz J, Weisspapir M. Vehicle for topical delivery of anti-inflammatory compounds. Patent No., WO/2006/096955, 2006.
19. Warren R, Reed J. Topical tanning compositions. Patent No., EP19870306848, 1989.
20. Suresh M, Nadakatti VN. Detergent bar and process for manufacture. US Patent No., US20060287206, 2006.
21. In-Kwon H,Young K, Hung-Sik K, Donggeun S, Woon-Won J, Hee JC, Yu-Kyoung O. Thermosensitive and mucoadhesive delivery systems of mucosal vaccines. Methods 2006;38 (2):106-111.
22. Pfaller MA, Diekema DJ, Sheehan DJ. Interpretive breakpoints for fluconazole and Candida revisited: A blueprint for the future of antifungal susceptibility testing. Clin. Microbiol. Rev. 2006;19 (2):435-447.
23. Kahn M. Bioavailability of vitamin B12 using a small-volume nebulizer ophthalmic drug delivery system. Clin. Experim. Ophthalmol. 2005;33 (4):402-407.
24. Chew NYK, Reed BL, Morgan TM, Finnin BC. Topical delivery of antifungal agents. US Patent No., US20040081684, 2004.
25. Friedlander SF. The evolving role of itraconazole, fluconazole and terbinafine in the treatment of Tinea capitis. Pediatr. Infect. Dis. J. 1999;18 (2):205-210.